Discover open access scientific publications

Search, annotate, share and cite publications

Publications by H. Maisonneuve

A Multicenter Phase II Study of Single-Agent Enzastaurin in Previously Treated Waldenstrom Macroglobulinemia

Clinical Cancer Research

Cancer Research

Oncology

2012

English

Evaluation of the (R)VAD+C Regimen for the Treatment of Newly Diagnosed Mantle Cell Lymphoma. Combined Results of Two Prospective Phase II Trials From the French GOELAMS Group

Haematologica

Hematology

2010

English

Increased Ccnd1 Fish Signals Are Associated With Worse Prognosis in Mantle Cell Lymphoma

Hematological Oncology

English

Refinement of Mum1 Expression Threshold for Double Positive Cd10+ Mum1+ Diffuse Large B Cell Lymphoma Allows a Better Cell of Origin Classification for GCB Subtype

Hematological Oncology

English

Obinutuzumab Plus Dhap Followed by Autologous Stem Cell Transplantation (Asct) Plus Obinutuzumab Maintenance Provides a High MRD Response Rate in Untreated MCL Patients. Results of Lyma-101 Trial, a Lysa Group Study

Hematological Oncology

English

Rituximab Plus Lenalidomide Is as Effective as Immunochemotherapy in the Eradication of Molecular Disease in Untreated Follicular Lymphoma: Relevance Lysa Ancillary Study

Hematological Oncology

English

Large Granular Lymphocyte Leukemia With Pure Red Cell Aplasia Associated With Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy: An Unfortuitous Association?

International Journal of Immunopathology and Pharmacology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by H. Maisonneuve

A Multicenter Phase II Study of Single-Agent Enzastaurin in Previously Treated Waldenstrom Macroglobulinemia

Evaluation of the (R)VAD+C Regimen for the Treatment of Newly Diagnosed Mantle Cell Lymphoma. Combined Results of Two Prospective Phase II Trials From the French GOELAMS Group

Increased Ccnd1 Fish Signals Are Associated With Worse Prognosis in Mantle Cell Lymphoma

Refinement of Mum1 Expression Threshold for Double Positive Cd10+ Mum1+ Diffuse Large B Cell Lymphoma Allows a Better Cell of Origin Classification for GCB Subtype

Obinutuzumab Plus Dhap Followed by Autologous Stem Cell Transplantation (Asct) Plus Obinutuzumab Maintenance Provides a High MRD Response Rate in Untreated MCL Patients. Results of Lyma-101 Trial, a Lysa Group Study

Rituximab Plus Lenalidomide Is as Effective as Immunochemotherapy in the Eradication of Molecular Disease in Untreated Follicular Lymphoma: Relevance Lysa Ancillary Study

Large Granular Lymphocyte Leukemia With Pure Red Cell Aplasia Associated With Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy: An Unfortuitous Association?